SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise:
SEC Accession No. 0001193805-22-001647
Filing Date
2022-12-06
Accepted
2022-12-06 08:30:42
Documents
6

Document Format Files

Seq Description Document Type Size
1 prrn14a13616001_12062022.htm PRRN14A 322798
2 GRAPHIC image_001.jpg GRAPHIC 5638
3 GRAPHIC image_002.jpg GRAPHIC 5647
4 GRAPHIC image_003.jpg GRAPHIC 11494
5 GRAPHIC image_004.jpg GRAPHIC 18296
6 GRAPHIC image_005.jpg GRAPHIC 11728
  Complete submission text file 0001193805-22-001647.txt   397943
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Subject) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRRN14A | Act: 34 | File No.: 001-37942 | Film No.: 221446742
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET NEW YORK NY 10019
Business Address 250 WEST 55TH STREET NEW YORK NY 10019 212-915-2565
LifeSci Management Co LLC (Filed by) CIK: 0001955680 (see all company filings)

IRS No.: 000000000
Type: PRRN14A